Christine Blank


Pain, Anxiety Represent Barriers to Anti-VEGF Therapies for Costly Eye Conditions

November 17, 2021

Pain and fear/anxiety were the most common barriers to anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration and diabetic macular edema. Another study found that those conditions had a significant impact on patients’ quality of life and Medicare costs.

Posters Provide Evidence on COPD Treatment Considerations, Exacerbation Risk Assessment

November 16, 2021

Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting. Another poster validated the use of the COPD Treatment Ratio as a measure of exacerbation risk.

Study Identifies Alcohol Use as Potential Risk Factor for AMD Subtype

November 15, 2021

A new study provides genetic evidence that increased alcohol intake may be a causal risk factor for geographic atrophy, a type of advanced age-related macular degeneration (AMD), but doctors caution it may be too soon to advise patients about the risk.